EXHIBIT A
AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need to be filed with respect to the ownership by each of the undersigned of Ordinary Shares of Iterum Therapeutics plc.
| Date: June 6, 2018 | FRAZIER HEALTHCARE VII, L.P. By FHM VII, L.P., its general partner By FHM VII, L.L.C., its general partner | |||||
| By: | /s/ Steve R. Bailey | |||||
| Steve R. Bailey, Chief Financial Officer | ||||||
| Date: June 6, 2018 | FRAZIER HEALTHCARE VII-A, L.P. By FHM VII, L.P., its general partner By FHM VII, L.L.C., its general partner | |||||
| By: | /s/ Steve R. Bailey | |||||
| Steve R. Bailey, Chief Financial Officer | ||||||
| Date: June 6, 2018 | FHM VII, L.P. By FHM VII, L.L.C., its general partner | |||||
| By: | /s/ Steve R. Bailey | |||||
| Steve R. Bailey, Chief Financial Officer | ||||||
| Date: June 6, 2018 | FHM VII, L.L.C. | |||||
| By: | /s/ Steve R. Bailey | |||||
| Steve R. Bailey, Chief Financial Officer | ||||||
| Date: June 6, 2018 | By: | * | ||||
| James Topper | ||||||
| Date: June 6, 2018 | By: | * | ||||
| Patrick Heron | ||||||
| Date: June 6, 2018 | By: | * | ||||
| Nader Naini | ||||||
| Date: June 6, 2018 | By: | * | ||||
| Nathan Every | ||||||
| Date: June 6, 2018 | By: | * | ||||
| Brian Morfitt | ||||||
| Date: June 6, 2018 | *By: | /s/ Steve R. Bailey | ||||
| Steve R. Bailey, as Attorney-in-Fact | ||||||
This Schedule 13D was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on March 29, 2016.
Page 2